Bicyclic amines as CDK2 inhibitors
US11976073B2 · kind B2 · utility
1Cited by
27References
65Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2022 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Dec 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides bicyclic amines of Formula (I): and their pharmaceutically acceptable salts thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.